Cargando…

Single-dose tocilizumab blunts systemic inflammation in severe COVID-19 patients

Detalles Bibliográficos
Autores principales:	de Roquetaillade, Charles, Guillemin, Jérémie, Picod, Adrien, Mebazaa, Alexandre, Kimmoun, Antoine, Chousterman, Benjamin Glenn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590611/ https://www.ncbi.nlm.nih.gov/pubmed/34785118 http://dx.doi.org/10.1016/j.jcrc.2021.11.001

Ejemplares similares

Systemic Inflammation Evaluated by Interleukin-6 or C-Reactive Protein in Critically Ill Patients: Results From the FROG-ICU Study
por: Picod, Adrien, et al.
Publicado: (2022)

Beta-Blockers in COVID-ARDS: Inflammation or Hemodynamic?
por: de Roquetaillade, Charles, et al.
Publicado: (2022)

Role of Damage-Associated Molecular Patterns in Septic Acute Kidney Injury, From Injury to Recovery
por: Ludes, Pierre-Olivier, et al.
Publicado: (2021)

Added value of serial bio-adrenomedullin measurement in addition to lactate for the prognosis of septic patients admitted to ICU
por: Blet, Alice, et al.
Publicado: (2020)

Making things right! Shouldn't we screen patients with thromboembolic events for SARS-CoV-2 infection, during the pandemia?
por: de Roquetaillade, C., et al.
Publicado: (2021)

Plasma and Urinary Biomarkers Improve Prediction of Mortality through 1 Year in Intensive Care Patients: An Analysis from FROG-ICU
por: Davison, Beth A., et al.
Publicado: (2023)

Haemodynamic impact of positive end-expiratory pressure in SARS-CoV-2 acute respiratory distress syndrome: oxygenation versus oxygen delivery
por: Barthélémy, Romain, et al.
Publicado: (2021)

Immunity and inflammation: the neglected key players in congenital heart disease?
por: Wienecke, Laura M., et al.
Publicado: (2021)

Effects of levosimendan on occurrence of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a case–control study
por: Trinh-Duc, Antoine, et al.
Publicado: (2021)

Comparison of echocardiographic indices of right ventricular systolic function and ejection fraction obtained with continuous thermodilution in critically ill patients
por: Barthélémy, Romain, et al.
Publicado: (2019)

Management of Acute Heart Failure during an Early Phase
por: Takagi, Koji, et al.
Publicado: (2020)

Timing and causes of death in severe COVID-19 patients
por: de Roquetaillade, Charles, et al.
Publicado: (2021)

Increased anticoagulation reduces proximal deep vein thrombosis in mechanically ventilated COVID-19 patients: Venous thrombosis prevention & COVID-19
por: Voicu, Sebastian, et al.
Publicado: (2021)

Severity-Adjusted Dexamethasone Dosing and Tocilizumab Combination for Severe COVID-19
por: Hong, Jin Yeong, et al.
Publicado: (2022)

Unusual arterial thrombotic events in Covid-19 patients
por: de Roquetaillade, C., et al.
Publicado: (2021)

Relationship between positive end-expiratory pressure levels, central venous pressure, systemic inflammation and acute renal failure in critically ill ventilated COVID-19 patients: a monocenter retrospective study in France
por: Basse, Pierre, et al.
Publicado: (2023)

Protracted immune disorders at one year after ICU discharge in patients with septic shock
por: Riché, Florence, et al.
Publicado: (2018)

A network meta-analysis of therapeutic and prophylactic management of vasospasm on aneurysmal subarachnoid hemorrhage outcomes
por: Chousterman, Benjamin, et al.
Publicado: (2023)

Global differences in acute heart failure treatment: analysis of the STRONG‐HF site feasibility questionnaire
por: Novosadova, Maria, et al.
Publicado: (2023)

COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review
por: Benhadid-Brahmi, Yasmine, et al.
Publicado: (2022)

Accuracy of a multiparametric score based on pulse wave analysis for prediction of fluid responsiveness: ancillary analysis of an observational study
por: Neuschwander, Arthur, et al.
Publicado: (2020)

Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation
por: Khandaker, Golam M, et al.
Publicado: (2018)

Tracheostomy and long-term mortality in ICU patients undergoing prolonged mechanical ventilation
por: Cinotti, Raphaël, et al.
Publicado: (2019)

Tocilizumab for severe COVID-19: A promising intervention affecting inflammation and coagulation
por: Levi, Marcel
Publicado: (2020)

Prevalence and identification of crystalluria in critically ill patients: association between uric acid crystals and sepsis
por: Tabibzadeh, Nahid, et al.
Publicado: (2020)

Efficacy of Almitrine in the Treatment of Hypoxemia in Sars-Cov-2 Acute Respiratory Distress Syndrome
por: Barthélémy, Romain, et al.
Publicado: (2020)

Glucocorticoids alone versus tocilizumab alone or glucocorticoids plus tocilizumab in patients with severe SARS-CoV-2 pneumonia and mild inflammation()
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2021)

Tocilizumab in severe COVID-19
por: Lucio Liberato, Nicola, et al.
Publicado: (2020)

TOCILIZUMAB USE IN SEVERE COVID-19: A SINGLE CENTER EXPERIENCE
por: Poon, Joseph, et al.
Publicado: (2020)

Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis
por: Roumier, Mathilde, et al.
Publicado: (2020)

Immediate Amelioration of Severe Respiratory Distress in Sjögren's Syndrome with COVID-19 Treated with a Single Dose of Off-label Tocilizumab
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

SARS-CoV-2-associated encephalitis: arguments for a post-infectious mechanism
por: Picod, Adrien, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Piano, Salvatore, et al.
Publicado: (2020)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
por: Sarhan, Rania M., et al.
Publicado: (2022)

Pathophysiological Processes Underlying the High Prevalence of Deep Vein Thrombosis in Critically Ill COVID-19 Patients
por: Voicu, Sebastian, et al.
Publicado: (2021)

Radiomic analysis of abdominal organs during sepsis of digestive origin in a French intensive care unit
por: Boutin, Louis, et al.
Publicado: (2023)

Usefulness and safety of a dedicated team to prone patients with severe ARDS due to COVID-19
por: Kimmoun, Antoine, et al.
Publicado: (2020)

Inflammation characteristics and anti-inflammation treatment with tocilizumab of severe/critical COVID-19 patients: A retrospective cohort study
por: Hu, Qin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1302p00msg43i56su2i145jtt4